期刊文献+

腹腔镜下子宫肌瘤剔除术与开腹子宫肌瘤剔除术临床疗效分析 被引量:19

Clinical efficacy comparison: laparoscopic myomectomy and abdominal myomectomy
下载PDF
导出
摘要 目的:研究腹腔镜下子宫肌瘤剔除术与开腹子宫肌瘤剔除术临床疗效。方法:选择2008年1月~2012年1月我院接诊的152例子宫肌瘤患者进行研究。按照随机数表法,将患者随机分为实验组和对照组两组,每组各76例患者。实验组采用腹腔镜下子宫肌瘤剔除术对患者进行手术,对照组采用传统的开腹子宫肌瘤剔除术进行治疗。结果:治疗后,发现实验组患者的术中出血量明显少于对照组(P<0.05),实验组患者的手术时间、排气时间以及住院时间明显短于对照组(P<0.05),且实验组患者并发症的发生率(6.6%)明显低于对照组(30.3%),两组比较有显著性差异(P<0.05)。结论:腹腔镜下子宫肌瘤剔除术临床效果良好,值得临床推广应用。 Objectives: To compare the clinical efficacy between laparoscopic myomectomy and abdominal myomectomy. Methods: 152 patients with uterine fibroid from January 2008 to January 2012 were studied. The patients were randomly divided into the experimental group and the control group, 76 patients in each group. The experimental group were treated with laparo- scopic myomectomy, the control group were treated with abdominal myomectomy. Results: The bleeding volume of the experi- mental group patients was significantly less than that of the control group ( P 〈 0.05 ). The surgery time, exhaust time and hospi- ial stay of the experimental group were significantly shorter than those of the control group ( P 〈 0. 05 ). The incidence rate of complications of the experimental group patients ( 6. 6% ) was significantly lower than that of the control group ( 30. 3% ) ( P 〈 0.05 ). Conclusions: Laparoscopie myomectomy is worthy of clinical application.
作者 喻晓琴
出处 《中国性科学》 2013年第5期30-31,共2页 Chinese Journal of Human Sexuality
关键词 腹腔镜 子宫肌瘤剔除术 开腹 Peritoneoscope Hysteromyomectomy Laparotomy
  • 相关文献

参考文献9

二级参考文献50

共引文献203

同被引文献162

  • 1Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endo- crine Reviews, 2013, 34(1) : 130-162.
  • 2Quinn SD, Vedelago J, Kashef E, et al. Measurement of uterine fi- broid volume: a comparative accuracy and validation of methods study. European Journal of Obstetrics & Gynecology and Reproduc- tive Biology, 2013, 171(1) : 161 -165.
  • 3Varghese BV, Koohestani F, McWilliams M, et al. Loss of the re- pressor REST in uterine fibroids promotes aberrant G protein - cou- pled receptor 10 expression and activates mammalian target of rapam- ycin pathway. Proceedings of the National Academy of Sciences, 2013, 110(6) : 2187 -2192.
  • 4Kfishnamurthy GB, Tsibanakos I, Moustafa M, et al. Value of hyste- roseopy prior to uterine artery embolisation for fibroids: a hospital based retrospective study. Gynecological Surgery, 2013, 10( 1 ) : 41 -44.
  • 5Yin H, Lo JH, Kim J Y, et al. Expression profiling of nuclear recep- tors identifies key roles of NR4A subfamily in uterine fibroids. Mo- lecular Endocrinology, 2013, 27 (5) : 726 - 740.
  • 6Talaulikar VS, Manyonda 1T. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther, 2012,29(8) :655 -663.
  • 7HeY, Zeng Q, Dong S, et al. Associations between uterine fibroids and lifestyles including diet, physical activity and stress : a case - control study in China. Asia Pac J Clin Nutr,2013,22( 1 ) :109 -117.
  • 8Hoellen F, Griesinger G, Bohlmann MK. Theratzeutic drugs in the treatment of symptomatic uterine fibroids. Expert Opin Pharmacother, 2013,14(15) :2079 -2085.
  • 9Sabry M,A1 - Hendy A. Medical treatment of uterine leiomyoma. Reprod Sci. 2012,19(4) :339 -353.
  • 10Bohlmann MK, Hoellen F, Hunold P, et al. High - intensity focused ultrasound ablation of uterine fibroids - potential impact on fertility and pregnancy outcome. Geburtshilfc Frauenheilkd ,2014,74 ( 2 ) : 139 - 145.

引证文献19

二级引证文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部